Telehealth Treatment for Alcohol Use Disorder

Ria Health

Status: Enrolling

Conditions: Alcoholism; Alcohol Use Disorder; Alcohol Dependence

Treatments: Combination Product: Ria Treatment Platform

Study type: Interventional

Funder types: Other; Industry; NIH

Identifiers

NCT05747703

1A

Details and patient eligibility

About

Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Patients are followed for three months during which data are collected, including measures of alcohol consumption and its consequences.

Enrollment: 124 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• alcohol use disorder

Exclusion criteria

• inability to provide informed consent

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

124 participants in 2 patient groups

Ria Treatment Platfrom

Experimental group

Description:

The Ria Treatment Platform is a telehealth approach that includes medical assessment, prescription of clinically appropriate medications for alcohol use disorder, individual and group coaching, educational video modules, and monitoring of breath alcohol concentrations through a Bluetooth-enabled breathalyzer.

Treatment:

Combination Product: Ria Treatment Platform

waitlist control

No Intervention group

Description:

Patients in this arm will not be provided treatment during the study period.